1. Moyer V. Screening for lung cancer: US preventive services task force recommendation statement. Ann Intern Med. 2014;160:330–3.
2. Carter-Harris L, Gould M. Multilevel barriers to the successful implementation of lung cancer screening: why does it have to be so hard? Ann Am Thorac Soc. 2017;14(8):1261–5.
3. Herman C, Gill H, Eng J, Fajardo L. Screening for preclinical disease: test and disease characteristics. Am J Roentgenol. 2002;179(4):825–31.
4. United States preventive services taskforce. Uspreventiveservicestaskforceorg. 2022 [cited 26 February 2022]. https://www.uspreventiveservicestaskforce.org/uspstf/.
5. Final National Coverage Determination on Screening for Lung Cancer with Low Dose Computed Tomography (LDCT). Cms.gov. 2015 [cited 26 February 2022]. https://www.cms.gov/medicare-coverage-database/view/ncacal-decision-memo.aspx?proposed=N&NCAId=274.